Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. | 53 832 | déclaré | 06 mai 2022 | tx 1+53 832 |
| Amylyx Pharmaceuticals, Inc. | 24 372 | déclaré | 04 juin 2026 | tx 7+122 704 |
| Adicet Bio, Inc. | 14 414 | déclaré | 03 juin 2020 | tx 2+28 828 |
| Apellis Pharmaceuticals, Inc. | 0 | déclaré | 14 mai 2026 | tx 25+115 792−167 580 |
| COVETRUS, INC. | 0 | déclaré | 13 oct. 2022 | tx 7+36 188−36 188 |
| ADVANCED MAGNETICS INC | 0 | déclaré | 16 nov. 2020 | tx 9+51 417−51 417 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 04 juin 2026 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 24 372 | 0.00 USD | deriv |
| 14 mai 2026 | TENDER | Apellis Pharmaceuticals, Inc. | 30 666 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 3 062 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 5 744 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 7 961 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 3 544 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 3 877 | — | |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 14 684 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 37 500 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 11 199 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 8 554 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 7 441 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 27 600 | — | deriv |
| 14 mai 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 5 748 | — | deriv |
| 01 janv. 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 7 961 | 0.00 USD | |
| 01 janv. 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 14 684 | 0.00 USD | deriv |
| 05 juin 2025 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 25 000 | 0.00 USD | deriv |
| 01 janv. 2025 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 6 267 | 0.00 USD | |
| 01 janv. 2025 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 11 199 | 0.00 USD | deriv |
| 06 juin 2024 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 25 000 | 0.00 USD | deriv |
| 01 janv. 2024 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 3 341 | 0.00 USD | |
| 01 janv. 2024 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 5 748 | 59.86 USD | deriv |
| 08 juin 2023 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 16 985 | 0.00 USD | deriv |
| 01 janv. 2023 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 3 867 | 0.00 USD | |
| 01 janv. 2023 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 7 441 | 0.00 USD | deriv |
1 achat déclaré après au moins 12 mois de silence — dernière occurrence le 10 août 2021.